COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,445 Articles (22,835 medRxiv, 8,610 bioRxiv)

Most recent first Previous |  Page 979: Articles 9781-9790  | Next

Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epithelia
Kocher, J., Arwood, L., Roberts, R., Henson, I., Annas, A., Emerson, D., Stasko, N., Fulcher, M. L., Brotton, M., Randell, S. H., Cockrell, A.
10.1101/2022.01.25.477616 — Posted: 2022-01-31
Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants
Lee, I.-J., Sun, C.-P., Wu, P.-Y., Lan, Y.-H., Wang, I.-H., Liu, W.-C., Tseng, S.-C., Tsung, S.-I., Chou, Y.-C., Kumari, M., Chang, Y.-W., Chen, H.-F., Lin, Y.-S., Chen, T. -Y., Chiu, C.-W., Hsieh, C.-H., Chuang, C.-Y., Lin, C.-C., Cheng, C.-M., Lin, H.-T., Chen, W.-Y., Chiang, P.-C., Lee, C.-C., Liao, J. C., Wu, H.-C., Tao, M.-H.
10.1101/2022.01.31.478406 — Posted: 2022-01-31
Susceptibility of wild canids to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Porter, S. M., Hartwig, A. E., Bielefeldt-Ohmann, H., Bosco-Lauth, A. M., Root, J. J.
10.1101/2022.01.27.478082 — Posted: 2022-01-31
Combating the SARS-CoV-2 Omicron variant with non-Omicron neutralizing antibodies
Wang, Y., Zhang, X., Liu, J., Wang, Y., Zhan, W., Liu, M., Zhang, M., Wang, Q., Liu, Q., Zhu, T.-Y., Wen, Y., Chen, Z., Zhao, J., Wu, F., Sun, L., Huang, J.
10.1101/2022.01.30.478305 — Posted: 2022-01-31
An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa
Vesin, B., Lopez, J., Noirat, A., Authie, P., Fert, I., Le Chevalier, F., Moncoq, F., Nemirov, K., Blanc, C., Planchais, C., Mouquet, H., Guinet, F., Hardy, D., Gerke, C., Anna, F., Bourgine, M., MAJLESSI, L., Charneau, P.
10.1101/2022.01.30.478159 — Posted: 2022-01-31
SARS-CoV-2 leverages airway epithelial protective mechanism for viral infection
Greaney, A. M., Raredon, M. S. B., Kochugaeva, M. P., Niklason, L. E., Levchenko, A.
10.1101/2022.01.29.478335 — Posted: 2022-01-31
Increasing SARS-CoV-2 mutations against vaccination-acquired immunity
Konishi, T.
10.1101/2022.01.30.22270133 — Posted: 2022-01-31
Are high urea values before intravenous immunoglobulin replacement a risk factor for COVID-related mortality?
Aytekin, G., ATAYIK, E.
10.1101/2022.01.29.22270080 — Posted: 2022-01-31
Estimating COVID-19 Vaccination Effectiveness Using Electronic Health Records of an Academic Medical Center in Michigan
Roberts, E., Gu, T., Mukherjee, B., Fritsche, L. G.
10.1101/2022.01.29.22269971 — Posted: 2022-01-31
"Populist Attitude and Conspiracist beliefs contribution to the overconfidence about the risk of Covid-19: implications for Preventive Health Behaviors"
Giuliani, A., Presaghi, F.
10.1101/2022.01.30.22269992 — Posted: 2022-01-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).